Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
PP 30408 01ONC22007GLOW studie: PP 30408 01ONC22007 Glioblastoma targeted treatment option maximization by WGS (GLOW)
van Linde, M. (Project Leader)
06/06/2024 → 31/05/2028
Project: Research
-
BP42573 studie: BP42573 studie
van Laarhoven, H. (Principal investigator) & van Linde, M. (Project Leader)
28/04/2022 → 27/04/2026
Project: Research
-
01ONC21013 BP42573 studie: AN OPEN-LABEL, MULTICENTER, PHASE I STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND PRELIMINARY CLINICAL ACTIVITY OF RO7428731 IN PARTICIPANTS WITH GLIOBLASTOMA EXPRESSING MUTANT EPIDERMAL GROWTH FACTOR R
van Linde, M. (Project Leader)
22/04/2022 → 27/04/2026
Project: Research
-
01ONC19005A EORTC 1709-BTG: EORTC 1709-BTG A phase III trial of marizomib in combination with standard temozolomide-based radiochemotherapy versus standard temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma
van Linde, M. (Project Leader)
06/03/2018 → 31/12/2022
Project: Research
-
Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials
Brouwer, C. G., Douma, J. A. J., Kuip, E. J. M., Zweegman, S., van de Donk, N. W. C. J., Hopman, M. T. E., van Linde, M. E., Verheul, H. M. W. & Buffart, L. M., Jul 2024, In: Journal of the National Comprehensive Cancer Network. 22, 5, p. 323-330 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Network analysis used to investigate the interplay among somatic and psychological symptoms in patients with cancer and cancer survivors: a scoping review
Doppenberg-Smit, G. E., Lamers, F., van Linde, M. E., Braamse, A. M. J., Sprangers, M. A. G., Beekman, A. T. F., Verheul, H. M. W. & Dekker, J., 2024, (E-pub ahead of print) In: Journal of cancer survivorship.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access3 Citations (Scopus) -
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma
Janssen, J. B. E., Brahm, C. G., Driessen, C. M. L., Nuver, J., Labots, M., Kouwenhoven, M. C. M., Sanchez Aliaga, E., Enting, R. H., de Groot, J. C., Walenkamp, A. M. E., van Linde, M. E. & Verheul, H. M. W., 2024, In: Brain Communications. 6, 4, p. fcae241 fcae241.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Toward an improved conceptualization of emotions in patients with cancer
Dekker, J., Doppenberg-Smit, E., Braamse, A., Lamers, F., van Linde, M., Verheul, H. M. W., Sprangers, M. & Beekman, A. T. F., 2024, In: Frontiers in psychiatry. 15, 1352026.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access1 Citation (Scopus) -
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis
Belgers, V., Röttgering, J. G., Douw, L., Klein, M., Ket, J. C. F., van de Ven, P. M., Würdinger, T., van Linde, M. E., Niers, J. M., Weber, M., Olde Rikkert, M. G., Lopez-Sendon, J., Arrieta, O., Svendsen, K. B., Chagas, M. H. N., de Almeida, C. M. O., Kouwenhoven, M. C. M. & de Witt Hamer, P. C., 1 Feb 2023, In: Cannabis and cannabinoid research. 8, 1, p. 41-55 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access5 Citations (Scopus)